Physician profile
Eric L Gressen
NPI 1144242660
$3,800.00
in general payments reported to CMS, 2019-2025
32 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,076 · 2020: $202 · 2021: $270 · 2022: $173 · 2023: $287 · 2024: $1,478 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,517 · Travel and Lodging: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,517.25 |
| Travel and Lodging | $562.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $973.67 | 2024-2025 | Barrigel |
| Boston Scientific Corporation | $430.17 | 2019-2025 | Spaceoar Vue System - 10ml, Therasphere Y90 Glass Microspheres 10 Gbq, General - Interventional Oncology |
| Astrazeneca Pharmaceuticals LP | $352.29 | 2019-2025 | Imfinzi, Tagrisso |
| Bayer Healthcare Pharmaceuticals INC. | $208.15 | 2019-2024 | |
| Novocure INC. | $179.94 | 2019-2025 | Optune, Optune Gio |
| Eisai INC. | $158.41 | 2019-2024 | |
| Astellas Pharma US INC | $117.87 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $114.93 | 2023-2024 | Libtayo |
| Novartis Pharmaceuticals Corporation | $113.56 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $112.39 | 2023-2024 | Orgovyx |
| Genzyme Corporation | $89.13 | 2019-2022 | |
| Lilly USA, LLC | $88.86 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $85.54 | 2019-2024 | Lynparza, Keytruda |
| Myriad Genetic Laboratories, INC. | $82.12 | 2024-2025 | Prolaris |
| Celgene Corporation | $78.23 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $76.83 | 2019-2025 | Aralast |
| Tesaro, INC. | $70.97 | 2019 | |
| Foundation Medicine, INC. | $58.21 | 2019-2020 | |
| Puma Biotechnology, INC. | $49.35 | 2019-2020 | |
| Pharmacyclics LLC, An Abbvie Company | $48.69 | 2019 | |
| Telix Pharmaceuticals | $46.91 | 2023-2024 | Illuccix |
| Dilon Technologies, INC. | $41.00 | 2024 | Hemoblast Bellows |
| Accuray Incorporated | $33.16 | 2024 | |
| Progenics Pharmaceuticals, INC. | $28.89 | 2024 | |
| Seagen INC. | $24.45 | 2020 | |
| Bioprotect Medical, INC. | $23.95 | 2024 | Bioprotect Balloon Implant System |
| Palette Life Sciences, INC. | $23.94 | 2021 | |
| Pinnacle Biologics, INC | $21.35 | 2021 | |
| Philips North America LLC | $20.48 | 2025 | Vest Therapy Und |
| E.R. Squibb & Sons, L.L.C. | $15.77 | 2019 | |
| Emd Serono, INC. | $15.48 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Gressen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.